Halis, F. Et Al. 2021. Effects of 5α-reductase inhibitor therapy with dutasteride on bone metabolism in patients with benign prostatic hyperplasia. Kuwait Medical Journal , vol.53, no.2 , 162-166.

Halis, F., Oguz, U., Cimen, H. I., Atik, Y. T., BAYDİLLİ, N., & Gokce, A., (2021). Effects of 5α-reductase inhibitor therapy with dutasteride on bone metabolism in patients with benign prostatic hyperplasia. Kuwait Medical Journal , vol.53, no.2, 162-166.

Halis, Fikret Et Al. "Effects of 5α-reductase inhibitor therapy with dutasteride on bone metabolism in patients with benign prostatic hyperplasia," Kuwait Medical Journal , vol.53, no.2, 162-166, 2021

Halis, Fikret Et Al. "Effects of 5α-reductase inhibitor therapy with dutasteride on bone metabolism in patients with benign prostatic hyperplasia." Kuwait Medical Journal , vol.53, no.2, pp.162-166, 2021

Halis, F. Et Al. (2021) . "Effects of 5α-reductase inhibitor therapy with dutasteride on bone metabolism in patients with benign prostatic hyperplasia." Kuwait Medical Journal , vol.53, no.2, pp.162-166.

@article{article, author={Fikret Halis Et Al. }, title={Effects of 5α-reductase inhibitor therapy with dutasteride on bone metabolism in patients with benign prostatic hyperplasia}, journal={Kuwait Medical Journal}, year=2021, pages={162-166} }